Our modern high-calorie, low-activity lifestyle is wreaking havoc on our bodies, provoking deadly diseases. The EU-funded NutrientSensingVivo project provides a better understanding of how the availability of food changes our metabolism. This knowledge offers new ways to prevent cancer, improve health and extend citizens’ life expectancy.
Identifying the specific genetic mutations that cause cancer has always been a challenge. The EU-funded NONCODRIVERS project offers a solution with a pioneering approach that applies machine learning based modelling to tumour data. This could lead to more personalised therapies that save the lives of thousands of citizens every year.
The EU-funded POTENT project has been developing a new type of drug delivery system for glioblastoma, an aggressive form of brain cancer. It can considerably improve treatment outcomes for patients and increase their life expectancy. Clinical trials could start in 2 to 4 years, a step closer to making the system available for the patients that could most benefit from it.
If countries can't train high-quality research staff, they will struggle to deliver innovative cancer treatments. An EU-funded project enabled four academic institutions to exchange staff and share best practices, resulting in various career advancements and successful research grant applications. These will benefit citizens through the researchers' expanding skills to advance cancer treatments.
Patients who've gone through chemotherapy know that as effective as it may be, it also causes a lot of damage to otherwise healthy cells. The EU-funded NANOCARGO project has pushed a solution forward for breast cancer that would avoid such damage. This breakthrough could benefit the many thousands upon thousands of women in Europe who undergo treatment for breast cancer every year.
A groundbreaking EU-funded project has created a new method for developing multidrug cancer treatments. Many of the cancers this method targets have proven very difficult to treat with conventional medicines. As a result, this innovation has the potential to save thousands of lives every year.
EU-funded researchers have applied engineering know-how to understand what controls the mechanical strength of living cells. Their findings offer new insights into the spread of cancers as well as into diseases of the heart and nervous system.
What is the best way to tackle sarcomas? Although clinical trials help to generate insight, they are hard to set up for rare diseases. An EU-funded project has organised several trials focusing on these malignancies, providing insight that is already helping to save more lives. It has also paved the way for further research to help patients.
EU-funded researchers are aiming to develop a new class of drugs to treat and even cure multiple sclerosis, building on groundbreaking research into previously unexploited mechanisms of an ancestral metabolic molecule the helps regulate the immune system of all humans and mammals.
EU-funded researchers have developed an ultrasensitive test to rapidly, accurately and cost-effectively diagnose disease, underpinned by innovative biosensing technology that could help combat the COVID-19 pandemic, HIV and cancer.
